HSD17B12 and neuroblastoma: Our investigation of lipid metabolism following the silencing of HSD17B12 or genome editing on the rs2863002 SNP revealed a significant impact on the lipid profiles and downregulation of key lipid molecules in these in vitro neuroblastoma cellular models.